Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Ruthenium”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Preparation of ruthenium(II) and ruthenium(III) myoglobin and the reaction of dioxygen, and carbon monoxide, with ruthenium(II) myoglobin.

Ruthenium myoglobins have been prepared by the reconstitution of horse heart apomyoglobin with either ruthenium(II) or ruthenium(III) mesoporphyrin IX (MpIX) derivatives. The ruthenium(II) and -(III) myo globins (RuMb and RuMb+, respectively) contain one ruthenium porphyrin/heme binding site; the species are readily interconverted using dithionite for reduction and bromine for oxidation. RuMb binds carbon monoxide to give the known carbonyl complex. Reversible oxygenation occurs readily with protein-free RuII(MpIX) species in dimethylformamide, but RuMb in phosphate buffer is irreversibly oxidized by dioxygen to give RuMb+ via an outer sphere electron transfer mechanism.

Animals↗

Interaction between dioxoruthenium(VI) porphyrins and hydroxylamines: coordination of N-substituted hydroxylamine to ruthenium and X-ray crystal structures of ruthenium complexes with a unidentate nitrosoarene ligand.

The interactions between dioxoruthenium(VI) porphyrins 1 with N-phenylhydroxylamine or unsubstituted hydroxylamine are described. Reaction of complexes 1 with excess PhNHOH leads to isolation of bis(nitrosobenzene)ruthenium(II) porphyrins 3 and mono(nitrosobenzene)ruthenium(II) porphyrins 4. Both the types of ruthenium complexes are characterized by 1H NMR, IR, and UV/Vis spectroscopy, and mass spectrometry. The X-ray structure determinations on [Ru(II)(TPP)(PhNO)2] (3a), [Ru(II)(2,6-Cl-TPP)(PhNO)2] (3e), and [Ru(II)(4-MeO-TPP)(PhNO)(PhNH2)] (4d) (TPP tetraarylporphyrin) disclose a unidentate nitrosoarene coordination in all these complexes, with Ru-N(PhNO) bond lengths of 2.003(3) (3a, average), 1.991(3) (3e, average), and 2.042(2) A (4d). In the case of 4d, the Ru-N(PhNH2) bond length is found to be 2.075(3) A. Mechanistic investigations reveal the formation of intermediates [Ru(II)(Por)(PhNO)(PhNHOH)] (5; Por=porphyrin), a ruthenium complex with N-substituted hydroxylamine ligand, in the "1 + PhNHOH" system. The Ru-NH(OH)Ph moiety in 5 undergoes no rapid exchange with free PhNHOH in solution at room temperature, as revealed by 1H NMR spectroscopy. Unlike the interaction between complexes 1 and PhNHOH, reaction of such complexes with NH2OH affords nitrosylruthenium(II) porphyrins [Ru(II)(Por)(NO)(OH)] (6).

Catalysis↗

Toxicology and pharmacology of some ruthenium compounds: Vascular smooth muscle relaxation by nitrosyl derivatives of ruthenium and iridium.

A series of compounds were synthesized from ruthenium trichloride, and their ip LD50s were determined in mice: pentamminenitrosylruthenium(II) chloride, 8.9; chloronitrobis(2,2'-dipyridyl)ruthenium(II), 55;dichlorobis(2,2'-dipyridyl)ruthenium(II), 63; ruthenium trichloride, 108; and potassium pentachloronitrosylruthenate(II), 127 mg/kg. The two bis-bipyridyl complexes produced death in convulsions within minutes, whereas the remaining compounds resulted in long, debilitating courses with death occurring in 4-7d. When given in massive overdoses, however, the compounds with inorganic ligands also produced rapid convulsive death in mice, and when given iv to anesthetized cats, they produced respiratory arrest. The major toxic effects of all the complexes appeared to be due to the metal and not to its associated ligands. Only complexes having nitrosyl ligand specifically relaxed vascular smooth muscle. Potassium pentabromoiridate(III) also relaxed rabbit aortic strips that had been contracted by adrenergic agonists, but potassium pentachloroiridate(III) did not. None of the complexes was as active as nitroprusside in relaxing aortic strips or in decreasing arterial blood pressure in cats. No compound tested was as potent as cisplatin in antitumor activity. The pentamminenitrosylruthenium(II) complex also relaxed guinea pig ileum and frog rectus abdominus when these isolated muscles had been contracted by acetylcho line. It appears that these organoruthenium compounds may produce death in central respiratory arrest, as do the inorganic complexes when given iv or ip in massive overdoses. In minimally lethal doses, the complexes with inorganic ligands may affect a variety of contractile tissues, perhaps by a general mechanism involving Ca. These complexes are apt to be generally cytotoxic as well.

Animals↗

Preparation and Characterization of Polymer-Stabilized Ruthenium-Platinum and Ruthenium-Palladium Bimetallic Colloids and Their Catalytic Properties for Hydrogenation of o-Chloronitrobenzene.

Colloidal dispersions of poly(N-vinyl-2-pyrrolidone) (PVP)-stabilized ruthenium-platinum and ruthenium-palladium bimetallic colloids were prepared by NaBH4 reduction of the corresponding mixed-metal salts at room temperature and characterized by TEM, XPS, and XRD. The resulting bimetallic colloids were used as catalysts for the selective hydrogenation of o-chloronitrobenzene (o-CNB) in methanol at 303 K under 0.1 MPa of hydrogen. It was observed that the catalytic performance of PVP-stabilized ruthenium-platinum colloids (PVP-Ru/Pt) and ruthenium-palladium colloids (PVP-Ru/Pd) was dependent on their compositions and could be remarkably affected by some added metal cations. In the presence of cobalt ion, nearly 100% selectivity to o-chloroaniline (o-CAN) was achieved over PVP-Ru/Pt colloids at 100% conversion of o-CNB, with an activity two orders of magnitude higher than that of monometallic PVP-Ru colloid. Copyright 1999 Academic Press.

Journal Article↗

Facile Dehydrogenation of alpha-Amino Acids Chelated to a Ruthenium(II) Ion: (alpha-Imino acidato)ruthenium(II) Complexes.

(alpha-Imino acidato)ruthenium(II) complexes, [Ru(II){N(R(1))=C(R(2))CO(2)}L(2)](+) (R(1) = R(2) = Me or R(1) = R(2) = -(CH(2))(3)-; L = 2,2'-bipyridine (=bpy) or 1,10-phenanthroline (=phen)), were obtained by anodic oxidation at a constant potential of the corresponding (alpha-amino acidato)ruthenium(II) complexes, N-methylalaninato or prolinato complexes, in good to excellent yields. (alpha-Imino acidato)ruthenium(II) complexes are stable in neutral or acidic aqueous solution. The half-wave potentials of alpha-imino acidato complexes are 0.73-0.78 V (vs SCE), which are more positive than those of the corresponding alpha-amino acidato complexes, 0.55-0.59 V. The crystal structure of [Ru(pro-H(2))(bpy)(2)]ClO(4).3H(2)O (pro-H(2) = 1,2-didehydroprolinato) has been determined by single-crystal X-ray analysis. Crystallographic data: space group C2/c, a = 21.73(1) Å, b = 19.33(1) Å, c = 14.58(1) Å, beta = 114.91(5) degrees, Z = 8, R = 0.0352. The length of the C=N double bond of the alpha-imino acidate moiety is 1.294(5) Å, and Ru-N(imino nitrogen) = 2.042(3) Å. The chelate ring of the alpha-imino acidato ligand is planar.

Journal Article↗

Qualitative X-ray spectrometric study to demonstrate ruthenium in central nervous system structures, after intraperitoneal injection of ruthenium red to adult rats.

A qualitative X-ray spectrometric study oriented to demonstrate ruthenium (Ru) in central nervous system was made after intraperitoneal (i.p.) injection of ruthenium red (RuR) to adult rats. Ru signals were depicted in the brain synaptosomal fraction since 60 min after RuR i.p. administration, corresponding to the latency period of the convulsive model injecting RuR systemically to adult rats. Ru signals were initially detected in pineal gland and periventricular regions, whereas X-rays from Ru atoms in cerebral cortex were detected at longer time intervals after RuR i.p. injection. It is concluded that RuR, a non-liposoluble substance, when injected systemically, passes from the blood stream to brain parenchyma, probably through areas without blood-brain barrier, reaching the neural elements related to the mechanisms of production of convulsions.

Animals↗

Synthesis, characterisation, crystal structures, reactivity, and electrochemistry of ruthenium-nitrido, ruthenium-cobalt-imido and ruthenapyrrolidone carbonyl clusters containing alkyne ligands.

Thermolysis of [Ru3(CO)9(mu3-NOMe)(mu3-eta2-PhC2Ph)] (1) with two equivalents of [Cp*Co(CO)2] in THF afforded four new clusters, brown [Ru5(CO)8(mu-CO)3(eta5-C5Me5)(mu5-N)(mu4-eta2-PhC2Ph)] (2), green [Ru3Co2(CO)7(mu3-CO)(eta5-C5Me5)2(mu3-NH)[mu4-eta8-C6H4-C(H)C(Ph)]] (3), orange [Ru3(CO)7(mu-eta6-C5Me4CH2)[mu-eta3-PhC2(Ph)C(O)N(OMe)]] (4) and pale yellow [Ru2(CO)6[mu-eta3-PhC2(Ph)C(O)N(OMe)]] (5). Cluster 2 is a pentaruthenium mu5-nitrido complex, in which the five metal atoms are arranged in a novel "spiked" square-planar metal skeleton with a quadruply bridging alkyne ligand. The mu5-nitrido N atom exhibits an unusually low frequency chemical shift in its 15N NMR spectrum. Cluster 3 contains a triangular Ru2Co-imido moiety linked to a ruthenium-cobaltocene through the mu4-eta8-C6H4C(H)C(Ph) ligand. Clusters 4 and 5 are both metallapyrrolidone complexes, in which interaction of diphenylacetylene with CO and the NOMe nitrene moiety were observed. In 4, one methyl group of the Cp* ring is activated and interacts with a ruthenium atom. The "distorted" Ru3Co butterfly nitrido complex [Ru3Co(CO)5(eta5-C5Me5)(mu4-N)(mu3-eta2-PhC2Ph)(mu-I)2I] (6) was isolated from the reaction of 1 with [Cp*Co(CO)I2] heated under reflux in THF, in which a Ru-Ru wing edge is missing. Two bridging and one terminal iodides were found to be placed along the two Ru-Ru wing edges and at a hinge Ru atom, respectively. The redox properties of the selected compounds in this study were investigated by using cyclic voltammetry and controlled potential coulometry. 15N magnetic resonance spectroscopy studies were also performed on these clusters.

Journal Article↗

Binary, Ternary, and Quarternary Complexes of Ruthenium(II) Involving the Flexidentate ONNS Donor Mono(4-(4-tolyl)thiosemicarbazone) of 2,6-Diacetylpyridine (L(2)H). First Report on Ruthenium Complexes of a Mono(thiosemicarbazone) of a Diketone: Crystal Structure of [Ru(L(2))(PPh(3))(2)]ClO(4).

A series of Ru(II) complexes of the ONNS donor ligand mono(4-(4-tolyl)thiosemicarbazone) of 2,6-diacetylpyridine (L(2)H) synthesized by using three different ruthenium-containing starting materials RuCl(3).xH(2)O, Ru(PPh(3))(3)Cl(2), and [Ru(NH(3))(5)Cl]Cl(2) are reported. Chemical and electrochemical studies of the complexes [Ru(L(2))(PPh(3))(2)]ClO(4) (1), [Ru(L(2))(PPh(3))(2)]Cl (2), [Ru(L(2))(PPh(3))]ClO(4).EtOH (3), [Ru(L(2))(PPh(3))(bpy)]ClO(4) (4), [Ru(L(2))(PPh(3))(ophen)]ClO(4) (5), [Ru(L(2))(2)] (6), and [Ru(L(2))(L(2)H)]Cl (7) have been carried out. The structure of the compound [Ru(L(2))(PPh(3))(2)]ClO(4) (1) has been determined by single-crystal X-ray diffraction techniques. The crystals are triclinic, space group P&onemacr; with a = 12.716(1) Å, b = 13.213(1) Å, c = 15.951(1) Å, alpha = 87.66(1) degrees, beta = 73.81(1) degrees, gamma = 70.93(1) degrees, and Z = 2, where the deprotonated ligand mono(4-(4-tolyl)thiosemicarbazone) of 2,6-diacetylpyridine (L(2)) is chelated to the Ru(II) center through the oxygen of the carbonyl group, pyridine ring nitrogen, imine nitrogen, and the thiolate sulfur atoms. Strong coordination of the carbonyl group suggested from its IR spectral characteristics has been confirmed from the appreciable shortening of the Ru-O bond and lengthening of the C=O bond in the structure of 1.

Journal Article↗

Ruthenium Complexes of Quinone Related Ligands: A Study of the Electrochemical Properties of 2-Aminothiophenolatobis(2,2'-Bipyridine)Ruthenium(II).

Electrochemical properties of the newly synthesized 2-amino thiophenolatobis(2,2'-bipyridine)ruthenium(II) [Ru(bpy)(2)(NH(2).S)cat](+) (bpy = 2,2'-bipyridine, (NH(2).S) = 2-aminothiophenolate) are reported, using microelectrode, disk electrode, rotating disk electrode cyclic voltammetry, spectroelectrochemistry, and differential pulse voltammetry. The results are compared with the electrochemical properties of the previously studied [Ru(II)(bpy)(2)LL](n)()(+) compounds, where LL are 1,2-dihydroxybenzene (O.O), 2-aminophenol (NH(m)().O), and 1,2-diaminobenzene (NH(m)().NH(m)()). These ligands can exist in protonated (m = 2) or deprotonated (m = 1) forms. By means of cyclic voltammetry, the deprotonated [Ru(II)(bpy)(2)(NH.S)](0) displayed a series of one-electron reversible redox waves, consistent with the previously observed results for the [Ru(II)(bpy)(2)LL](n)()(+) complexes. However, the reversible waves observed for protonated [Ru(II)(bpy)(2)(NH(2).S) cat](+) are inconsistent with the irreversible waves observed for protonated [Ru(II)(bpy)(2)LL](n)()(+) complexes. An ECE mechanism is proposed to account for these differences and is used to interpret and simulate the cyclic voltammograms (CV)s of [Ru(II)(bpy)(2)(NH(2).S)cat](+) in organic solvents.

Journal Article↗

Block by ruthenium red of the ryanodine-activated calcium release channel of skeletal muscle.

The effects of ruthenium red and the related compounds tetraamine palladium (4APd) and tetraamine platinum (4APt) were studied on the ryanodine activated Ca2+ release channel reconstituted in planar bilayers with the immunoaffinity purified ryanodine receptor. Ruthenium red, applied at submicromolar concentrations to the myoplasmic side (cis), induced an all-or-none flickery block of the ryanodine activated channel. The blocking effect was strongly voltage dependent, as large positive potentials that favored the movement of ruthenium red into the channel conduction pore produced stronger block. The half dissociation constants (Kd) for ruthenium red block of the 500 pS channel were 0.22, 0.38, and 0.62 microM, at +100, +80, and +60 mV, respectively. Multiple ruthenium red molecules seemed to be involved in the inhibition, because a Hill coefficient of close to 2 was obtained from the dose response curve. The half dissociation constant of ruthenium red block of the lower conductance state of the ryanodine activated channel (250 pS) was higher (Kd = 0.82 microM at +100 mV), while the Hill coefficient remained approximately the same (nH = 2.7). Ruthenium red block of the channel was highly asymmetric, as trans ruthenium red produced a different blocking effect. The blocking and unblocking events (induced by cis ruthenium red) can be resolved at the single channel level at a cutoff frequency of 2 kHz. The closing rate of the channel in the presence of ruthenium red increased linearly with ruthenium red concentration, and the unblocking rate of the channel was independent of ruthenium red concentrations. This suggests that ruthenium red block of the channel occurred via a simple blocking mechanism. The on-rate of ruthenium red binding to the channel was 1.32 x 10(9) M-1 s-1, and the off-rate of ruthenium red binding was 0.75 x 10(3) s-1 at +60 mV, in the presence of 200 nM ryanodine. The two related compounds, 4APd and 4APt, blocked the channel in a similar way to that of ruthenium red. These compounds inhibited the open channel with lower affinities (Kd = 170 microM, 4APd; Kd = 656 microM, 4APt), and had Hill coefficients of close to 1. The results suggest that ruthenium red block of the ryanodine receptor is due to binding to multiple sites located in the conduction pore of the channel.

Animals↗

Characterization of ruthenium red-binding sites of the Ca(2+)-ATPase from sarcoplasmic reticulum and their interaction with Ca(2+)-binding sites.

Sarcoplasmic reticulum Ca(2+)-ATPase has previously been shown to bind and dissociate two Ca2+ ions in a sequential mode. This behaviour is confirmed here by inducing sequential Ca2+ dissociation with Ruthenium Red. Ruthenium Red binds to sarcoplasmic reticulum vesicles (6 nmol/mg) with a Kd = 2 microM, producing biphasic kinetics of Ca2+ dissociation from the Ca(2+)-ATPase, decreasing the affinity for Ca2+ binding. Studies on the effect of Ca2+ on Ruthenium Red binding indicate that Ruthenium Red does not bind to the high-affinity Ca(2+)-binding sites, as suggested by the following observations: (i) micromolar concentrations of Ca2+ do not significantly alter Ruthenium Red binding to the sarcoplasmic reticulum; (ii) quenching of the fluorescence of fluorescein 5'-isothiocyanate (FITC) bound to Ca(2+)-ATPase by Ruthenium Red (resembling Ruthenium Red binding) is not prevented by micromolar concentrations of Ca2+; (iii) quenching of FITC fluorescence by Ca2+ binding to the high-affinity sites is achieved even though Ruthenium Red is bound to the Ca(2+)-ATPase; and (iv) micromolar Ca2+ concentrations prevent inhibition of the ATP-hydrolytic capability by dicyclohexylcarbodi-imide modification, but Ruthenium Red does not. However, micromolar concentrations of lanthanides (La3+ and Tb3+) and millimolar concentrations of bivalent cations (Ca2+ and Mg2+) inhibit Ruthenium Red binding as well as quenching of FITC-labelled Ca(2+)-ATPase fluorescence by Ruthenium Red. Studies of Ruthenium Red binding to tryptic fragments of Ca(2+)-ATPase, as demonstrated by ligand blotting, indicate that Ruthenium Red does not bind to the A1 subfragment. Our observations suggest that Ruthenium Red might bind to a cation-binding site in Ca(2+)-ATPase inducing fast release of the last bound Ca2+ by interactions between the sites.

Animals↗

Ruthenium red as a stain for electron microscopy. Some new aspects of its application and mode of action.

Commercial ruthenium red has been tested for its purity by spectrophotometry. Impurities detected by this method could be abolished by nitric acid-precipitation of ruthenium brown. This substance has no effect on cell surface staining and converts almost completely to ruthenium red under the conditions used in electron microscopy. It was found, by photometric analysis, that in the ruthenium red-osmium tetroxide-cacodylate combination, generally used for cell surface staining, chemical reactions between ruthenium red and osmium tetroxide occur. As aerial oxidation of hexammineruthenium2+ leads to a product with some surface staining capability, it is suggested that an oxidized product of ruthenium red is responsible for binding to cellular components, and that a reduced product of osmium tetroxide gives an additional contrast enhancement. In ruthenium red-osmium dioxide combinations ruthenium red seems to bind to cell surfaces without any molecular alteration, and contrast is gained by the model proposed by Blanquet (1976b). The latter method could open a way for investigating the binding of ruthenium red to certain natural compounds involved in calcium transport, as postulated by a number of authors. Both ruthenium-osmium combinations differ in their cell surface staining ability. The ruthenium red-osmium dioxide combination tends to form distinct subunits, whereas the osmium tetroxide variety stains homogeneously. In combination with osmium dioxide, the surface staining is affected by EDTA, and, in contrast to osmium tetroxide, a successive application of ruthenium red and osmium dioxide as possible.

Blood Platelets↗

The interaction of ruthenium red with surface charges controlling excitation-contraction coupling in frog sartorius.

Frog sartorii were incubated in choline Ringer solution containing different amounts of the cationic dye ruthenium red, and were subsequently superfused with ruthenium red-free solution. The contraction threshold was measured during and after the incubation at different calcium and magnesium concentrations. During incubation in ruthenium red the threshold potential is slowly shifted to more positive values depending on time of incubation and the ruthenium red concentration (10--300 microns). After ca. 40 min of incubation a saturation potential is reached. The threshold shift is already maximal (-38mV threshold potential) at 30 microns of ruthenium ret regardless of the calcium concentration up to 5 mM. Omitting calcium from the incubation solution or adding 0.5 mM magnesium instead of calcium resulted in a more negative saturation potential (-48 mV). Washing the muscle in ruthenium red-free solution for 60 min after the incubation fails to reverse the threshold shift completely. The irreversible component of the threshold shift does not depend on the divalent cation concentration during incubation as long as the saturation value during incubation is more positive than -50 mV. The contraction threshold achieved after incubation with ruthenium red is dependent on the divalent cation concentration with calcium being twice as effective as magnesium. The effect of ruthenium red is greatest at small divalent cation concentrations and not significant at 50 mM. Incubating muscles with 5 units of neuraminidase shifted the concentration threshold to more positive potentials to the same extent as incubation with ruthenium red. Subsequent treatment of the neuraminidase-treated muscles with 30 microns of ruthenium red has no further effect on contraction threshold. The alternative experiment, first incubation with ruthenium red and then treatment with neuraminidase, gives the same results. The results are explained by the interaction of ruthenium red with membrane-bound sialic acid. This interaction is thought to result in a decrease in negative charges which results in a shift of the surface potential and hence of the contraction threshold to more positive potentials.

Animals↗